Position in BBNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,833,690
+$4,229,616 QoQ
Shares Held
308,468
+411.7% QoQ
Ownership
0.686%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBNX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $3,270,437,578 across 82 Medical Devices names. BBNX ranks #34 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
9,681,750 | $413,217,085 | |
| 2 | ABT |
Abbott Laboratories
|
4,193,058 | $380,478,079 | |
| 3 | PODD |
Insulet Corp
|
2,455,135 | $373,794,300 | |
| 4 | STE |
STERIS plc
|
1,377,297 | $290,017,425 | |
| 5 | MDT |
Medtronic plc
|
3,299,627 | $258,129,817 | |
| 6 | DXCM |
Dexcom Inc
|
3,237,720 | $218,060,438 | |
| 7 | LIVN |
LivaNova PLC
|
2,356,191 | $193,749,582 | |
| 8 | HAE |
Haemonetics Corp
|
2,266,489 | $169,986,675 |
All Filings in BBNX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,833,690 | 308,468 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $604,074 | 60,287 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,535,837 | 50,405 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,033,437 | 52,010 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $807,102 | 55,433 | Shares | Other | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||